What is needed for Western Balkan countries to close the gap in access - Luka Vončina MD, PhD
Luka Vončina
The EU countries are seems to be much more pragmatic when delivering innovative medicine to their patients comes about compared to Western Balkan countries. What is need and when can Western Balkan countries will close the gap dr Vončina explained in presentation.
Luka Vončina graduated as a Medical Doctor from the Zagreb School of Medicine, Croatia in 2002. In 2005, he graduated as MSc in International Health Policy from the London School of Economics, UK as a Chevening scholar. In 2013, he obtained his PhD in Biomedicine at the University of Split, Croatia.
From 2009 to 2011 he was Head of pricing and reimbursement of medicines and medical products for the Croatian National Health Insurance Fund. From 2012 to 2014 he worked for the Croatian Government as Assistant Minister of Health in charge of health services, reforms, inspectorates and EU funds. In that period, he served on the management boards of the European Medicines Agency, several large Croatian hospitals and the Standing Committee of the Regional Committee of WHO EURO. From 2014, he has been working as a consultant for governments, international organizations (in major part the World Bank Group) and industry in Europe, Asia and South America. His work is focused on pricing and reimbursement of medicines and medical products, health financing and public private partnerships in health. He has published extensively in international peer reviewed journals.
From 2009 to 2011 he was Head of pricing and reimbursement of medicines and medical products for the Croatian National Health Insurance Fund. From 2012 to 2014 he worked for the Croatian Government as Assistant Minister of Health in charge of health services, reforms, inspectorates and EU funds. In that period, he served on the management boards of the European Medicines Agency, several large Croatian hospitals and the Standing Committee of the Regional Committee of WHO EURO. From 2014, he has been working as a consultant for governments, international organizations (in major part the World Bank Group) and industry in Europe, Asia and South America. His work is focused on pricing and reimbursement of medicines and medical products, health financing and public private partnerships in health. He has published extensively in international peer reviewed journals.